Novartis Showcases Next-Generation Cardiovascular Therapies
BASEL, Switzerland, August 19, 2026 Novartis will present data from 10 abstracts across its cardiovascular portfolio at the 2026...
atrial fibrillation
Advertisement
Johnson & Johnson Wins FDA Approval for Dual Energy Platform
IRVINE, Calif., July 8, 2026 Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA)...
TCAI and St. David’s Medical Center Advance Cardiac Rhythm Innovation
Austin, Texas, USA — May 22, 2026 The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has...
Medtronic Affera Catheters Show Strong HRS 2026 Data
Galway, Ireland & Chicago, Illinois | April 25, 2026 Medtronic has announced significant clinical milestones for its Affera™ mapping...
Haemonetics VASCADE MVP XL Shows Superior Closure
BOSTON, April 24, 2026 Haemonetics Corporation has announced compelling new clinical data demonstrating the safety, efficacy, and superior performance...
Advertisements
Johnson & Johnson Launches VARIPULSE Pro in Europe
IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSE™ Pro, an...
Haemonetics Secures FDA Nod for VASCADE MVP XL Expansion
BOSTON, March 30, 2026 In a significant advancement for interventional cardiology and electrophysiology procedures, Haemonetics Corporation announced that the...
OMNY AF Study Shows Early Gains in AF Ablation
Boston, Massachusetts — February 6, 2026 Johnson & Johnson has presented early clinical outcomes from the OMNY AF Pilot...
Field Medical Reports PULSE AF Study Data
SAN DIEGO, Feb. 2026 — Field Medical presented new clinical findings from its PULSE clinical study evaluating pulsed field...
HUYABIO Reports Positive Phase 1 Data for AF Drug HBI-3000
SAN DIEGO | January 6, 2026 — HUYABIO International has announced positive Phase 1 clinical results for HBI-3000, a...
Advertisement
